Primary antibodies against SLC7A11 (Cell Signaling Technology, 12691, 1:500 dilution), iNOS (BD Biosciences, 610329, 1:500 dilution), 15LO1 (Abnova, H00000246-D01P, 1:1000 dilution), GPX4 (Abcam, 125066, 1:1000 dilution), POSTN (Santa Cruz Biotechnology, 67233, 1:500), and CCL26 (R&D Systems, AF653, 1:500 dilution) were used
However, caution is warranted, as some NF1-associated cases may aberrantly express Melan-A or MITF
GI side effects that peaked in weeks 1 to 20 largely resolved by week 40, even as patients remained on full maintenance dosing [9]
Bariatric surgery physically changes your digestive system , while GLP-1 medications rely on hormonal signaling to achieve their effects
I didn't give a fuck who the mayor was